ArticleTranslational stroke research2026
Association of Traditional and Novel Lipid Indicators With the Hemorrhagic Phenotype in Adult Moyamoya Disease: Implications for Phenotype Stratification.
Article in Translational stroke research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
To investigate the associations of traditional and novel lipid parameters with the hemorrhagic phenotype in adults with primary moyamoya disease (MMD) and to evaluate their value for phenotype discrimination and stratification. This retrospective dual-center cross-sectional study included 1,176 adults with primary MMD treated at Beijing Hospital and Beijing Tiantan Hospital between January 2022 and January 2026, including 857 patients with a non-hemorrhagic phenotype and 319 with a hemorrhagic phenotype. Traditional and derived lipid parameters were analyzed. Missing body mass index values were handled using multiple imputation. Multivariable logistic regression, restricted cubic spline analysis, receiver operating characteristic analysis, incremental discrimination analysis, sensitivity analyses, subgroup analyses, and exploratory mediation analysis were performed. Compared with patients with the non-hemorrhagic phenotype, those with the hemorrhagic phenotype had lower body mass index and higher levels of several cholesterol-related lipid parameters. In fully adjusted models, total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol were significantly associated with the hemorrhagic phenotype, with odds ratios for the highest versus lowest quartile of 3.435, 3.197, and 3.150, respectively. These indicators showed modest individual discriminative ability and provided limited incremental improvement when added to the basic clinical model. Sensitivity and subgroup analyses were generally consistent. Exploratory analyses identified BMI-related negative indirect effects. Cholesterol-related lipid parameters, particularly total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol, were associated with the hemorrhagic phenotype in adult primary MMD and may serve as supplementary markers for phenotype stratification.
Indexed as
Identifiers
42565908What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.